Curative Biotechnology, Inc., a biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications. It develops Metformin Reformulation to treat intermediate dry macular degeneration and geographic atrophy; IMT504, a novel immunotherapy to treat late-stage rabies; and CUBT906, a fully humanized CD56 monoclonal antibody carrying a cytotoxic drug conjugate directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor. The company has a licensing and co-development agreement with Mid-Atlantic BioTherapeutics, Inc. to develop IMT504 to treat late-stage rabies and COVID-19 vaccine; and development agreement with the University of Pennsylvania School of Veterinary Medicine for the development of a metformin-based ophthalmic formulation. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.
Frequently asked questions
What sector does Curative Biotechnology Inc (CUBT) operate in?
Curative Biotechnology Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Curative Biotechnology Inc (CUBT) current stock price?
As of the latest data, Curative Biotechnology Inc stock price is $0.77, with a previous close of $0.71. Curative Biotechnology Inc gained $0.06 in the last trading session, representing a 8.07% increase.
What is Curative Biotechnology Inc (CUBT) current market capitalization?
Curative Biotechnology Inc market cap is approximately 6.85 million.
What is Curative Biotechnology Inc (CUBT) Earnings Per Share (EPS)?
The trailing EPS is -$0.47.
What is Curative Biotechnology Inc (CUBT) EBITDA?
Curative Biotechnology Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -351.24 thousand.
Does Curative Biotechnology Inc (CUBT) pay dividends?
No. Curative Biotechnology Inc does not pay a dividend.
What is Curative Biotechnology Inc (CUBT) beta (volatility) score?
Curative Biotechnology Inc has a beta of 1.300, suggesting it is more volatile than the market.
